AU5169779A - Octahydro-1h-pyrrolo(2,3-g)isoquinoline pharmaceuticals - Google Patents

Octahydro-1h-pyrrolo(2,3-g)isoquinoline pharmaceuticals

Info

Publication number
AU5169779A
AU5169779A AU51697/79A AU5169779A AU5169779A AU 5169779 A AU5169779 A AU 5169779A AU 51697/79 A AU51697/79 A AU 51697/79A AU 5169779 A AU5169779 A AU 5169779A AU 5169779 A AU5169779 A AU 5169779A
Authority
AU
Australia
Prior art keywords
octahydro
pyrrolo
isoquinoline
pharmaceuticals
isoquinoline pharmaceuticals
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU51697/79A
Other versions
AU528685B2 (en
Inventor
Leo Berger
Gary Lee Olson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26754910&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU5169779(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US06/073,813 external-priority patent/US4260762A/en
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of AU5169779A publication Critical patent/AU5169779A/en
Application granted granted Critical
Publication of AU528685B2 publication Critical patent/AU528685B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/04—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU51697/79A 1978-10-13 1979-10-11 Octahydro-1h-pyrrolo(2,3-g)isoquinoline pharmaceuticals Ceased AU528685B2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US95094778A 1978-10-13 1978-10-13
US950947 1978-10-13
US73813 1979-09-10
US06/073,813 US4260762A (en) 1979-09-10 1979-09-10 Octahydro-1H-pyrrolo[2,3-g]isoquinolines

Publications (2)

Publication Number Publication Date
AU5169779A true AU5169779A (en) 1980-04-17
AU528685B2 AU528685B2 (en) 1983-05-12

Family

ID=26754910

Family Applications (1)

Application Number Title Priority Date Filing Date
AU51697/79A Ceased AU528685B2 (en) 1978-10-13 1979-10-11 Octahydro-1h-pyrrolo(2,3-g)isoquinoline pharmaceuticals

Country Status (18)

Country Link
EP (1) EP0010661B1 (en)
AR (2) AR228244A1 (en)
AU (1) AU528685B2 (en)
CA (1) CA1132553A (en)
CS (1) CS242858B2 (en)
DE (1) DE2967215D1 (en)
DK (1) DK430579A (en)
ES (2) ES8104806A1 (en)
FI (1) FI67548C (en)
HU (1) HU181883B (en)
IE (1) IE48965B1 (en)
IL (1) IL58438A (en)
MC (1) MC1285A1 (en)
NO (1) NO152873C (en)
NZ (1) NZ191830A (en)
PH (1) PH14835A (en)
PT (1) PT70310A (en)
SU (3) SU1014474A3 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MC1377A1 (en) * 1980-02-28 1982-01-19 Hoffmann La Roche ISOQUINOLEIN DERIVATIVES
EP0091565B1 (en) * 1982-03-29 1986-04-23 F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft Process for the manufacture of isoquinoline diones
US4732902A (en) * 1986-05-23 1988-03-22 Hoffmann-La Roche Inc. Pyrroloisoquinolinyl-dimethyloxoalkyl alkonoates and their use as antipsychotic agents
GB8828669D0 (en) * 1988-12-08 1989-01-11 Lilly Industries Ltd Organic compounds
BR9915500A (en) * 1998-11-20 2001-08-07 Basf Ag Process for the preparation of bis (oxime) monoethers, mono (oxy-ether), and, monooxime

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS51118799A (en) * 1975-04-10 1976-10-18 Sankyo Co Ltd Method for preparing pyridindole derivatives

Also Published As

Publication number Publication date
FI67548B (en) 1984-12-31
DK430579A (en) 1980-04-14
FI793183A (en) 1980-04-14
PT70310A (en) 1979-11-01
EP0010661B1 (en) 1984-09-12
NZ191830A (en) 1984-09-28
SU1014474A3 (en) 1983-04-23
SU1048985A3 (en) 1983-10-15
CS694579A2 (en) 1985-08-15
IL58438A0 (en) 1980-01-31
AR229096A1 (en) 1983-06-15
SU1109052A3 (en) 1984-08-15
NO152873C (en) 1985-12-04
EP0010661A2 (en) 1980-05-14
ES493015A0 (en) 1981-05-16
ES493014A0 (en) 1981-05-16
NO793301L (en) 1980-04-15
DE2967215D1 (en) 1984-10-18
EP0010661A3 (en) 1980-10-01
NO152873B (en) 1985-08-26
AR228244A1 (en) 1983-02-15
IE48965B1 (en) 1985-06-26
ES8104805A1 (en) 1981-05-16
FI67548C (en) 1985-04-10
HU181883B (en) 1983-11-28
CS242858B2 (en) 1986-05-15
CA1132553A (en) 1982-09-28
IL58438A (en) 1982-12-31
IE791944L (en) 1980-04-13
AU528685B2 (en) 1983-05-12
ES8104806A1 (en) 1981-05-16
MC1285A1 (en) 1980-07-22
PH14835A (en) 1981-12-16

Similar Documents

Publication Publication Date Title
AU537799B2 (en) Spray
AU4523779A (en) Septum
AU529068B2 (en) 1,2,3,5-tetrahydroimidazothienopyrimidin-2-ones
AU515352B2 (en) 1, 2-DIHYDRO-3H-PYRROLE (1, 2-a)-PYRROLE-1-NITRILES
AU5197779A (en) Antiviral 3,4-dihydro-3-oxo-quinoxaline
AU522422B2 (en) Rafozanide - polyvinylpyrrolidone complex
AU5118979A (en) 2,6-diaminoebularines
AU536015B2 (en) Rack
AU538454B2 (en) 4,4:-dinitrostilbene-2,2:-disulphonic acid
AU528685B2 (en) Octahydro-1h-pyrrolo(2,3-g)isoquinoline pharmaceuticals
AU507873B2 (en) 8b-ethyl-and 8b-methyl-4,5x-epoxymorphinan-6-compounds
AU525554B2 (en) Hexahydroindolo(4,3-fg)isoquinoline
AU4872179A (en) 2-amino-6-n,n-dimethylcarbamoyloxy-pyrimidines
AU529907B2 (en) Oxadiazolotriazine pharmaceuticals
AU516343B2 (en) PYRAZOLO (5, 1-a) ISOQUINOLINE
AU505434B1 (en) 2, 5 diketogluconic acid
SU694213A1 (en) Millinc system
AU522061B2 (en) 1-oxa-4-aza-2,6-disilacyclohexanes
AU522843B2 (en) Preparing 7,8-dichloro-tetrahydroiso-quinoline
AU4527079A (en) Electrothermal atomization
AU519842B2 (en) Mononitro-n-alkyl-3, 4-xylidines
AU5263379A (en) Pyrido-(4,3-c)-pyridazine pharmaceuticals
AU3837678A (en) Outerwear
AU6261480A (en) Spray
AU533935B2 (en) (1,3-thiazin)(3,4-b)isoquinoline derivatives